Christopher Sarchi, Chief Commercial Officer at Replimune Group, Inc. (REPL), sold 12,000 shares at $9.24 ($111K) on 2026-06-01, disclosed to the SEC on 2026-06-03.
Scheduled sale ($111k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| REPL | SELL | 2025-11-19 | $47K | — | Filing → |
| REPL | SELL | 2025-05-22 | $30K | — | Filing → |
| REPL | SELL | 2024-11-20 | $112K | — | Filing → |